Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses DOI Creative Commons
David Scheim, Peter Parry, David J. Rabbolini

et al.

Viruses, Journal Year: 2024, Volume and Issue: 16(4), P. 647 - 647

Published: April 22, 2024

Consistent with the biochemistry of coronaviruses as well established over decades, SARS-CoV-2 makes its initial attachment to host cells through binding spike protein (SP) sialylated glycans (containing monosaccharide sialic acid) on cell surface. The virus can then slide and enter via ACE2. SP attaches particularly tightly trillions red blood (RBCs), platelets endothelial in human body, each very densely coated acid surface molecules but having no ACE2 or minimal These interlaced attachments trigger aggregation, microvascular occlusion vascular damage that underlie hypoxia, clotting related morbidities severe COVID-19. Notably, two betacoronaviruses express a acid-cleaving enzyme are benign, while other three—SARS, MERS—are virulent. RBC aggregation experimentally induced several animal species using an injected polysaccharide caused most same This glycan is key disentangling controversies have arisen efficacy certain generic COVID-19 treatment agents safety SP-based vaccines. More broadly, disregard for active physiological role RBCs yields unreliable erroneous reporting pharmacokinetic parameters routinely obtained drugs bioactive detection plasma, whole-blood levels being up 30-fold higher. Appreciation elucidate underpinnings health conditions, including cardiovascular disease, therapeutic opportunities address them.

Language: Английский

The more things change, the more they stay the same: promises of bioeconomy and the economy of promises DOI Creative Commons
Dennis Eversberg, Philip Koch, Rosa Lehmann

et al.

Sustainability Science, Journal Year: 2023, Volume and Issue: 18(2), P. 557 - 568

Published: March 1, 2023

Abstract This editorial lays out the core themes of special feature and provides an overview contributions. It introduces main argument, namely that promises far-reaching change made by recent bioeconomy policies are in fact strategically directed at avoiding transformative to existing societal arrangements. Bioeconomy discourse showcases technological solutions purported solve sustainability ‘problems’ while sustaining economic growth, but avoids issues scalability, integration or negative consequences. Thus, policies, particularly latest versions predominantly European ‘bio-resource’ variety have rhetorically integrated a lot previous sustainability-minded criticism, serve ward off delay challenges unsustainable status quo, effect prolongating escalatory imperatives capitalist modernity root current crises. The editorial’s second part highlights contributions 13 featured articles, based on theoretical considerations as well policy analyses empirical case studies from range countries, make this argument.

Language: Английский

Citations

34

Replacing academic journals DOI Creative Commons
Björn Brembs, Philippe Huneman, Felix D. Schönbrodt

et al.

Royal Society Open Science, Journal Year: 2023, Volume and Issue: 10(7)

Published: July 1, 2023

Replacing traditional journals with a more modern solution is not new idea. Here, we propose ways to overcome the social dilemma underlying decades of inaction. Any needs only resolve current problems but also be capable preventing takeover by corporations: it replace decentralized, resilient, evolvable network that interconnected open standards and open-source norms under governance scholarly community. It monopolies connected genuine, functioning well-regulated market. In this market, substitutable service providers compete innovate according conditions community, avoiding sustained vendor lock-in. Therefore, body form community allow development infrastructures servicing entire research workflow. We redirection money from legacy publishers funding bodies broadening their minimal infrastructure requirements at recipient institutions include components replacing complementing journal functionalities. Such updated eligibility criteria agencies would help realign financial incentives for public interest.

Language: Английский

Citations

23

Challenges and opportunities for increasing the use of low-risk plant protection products in sustainable production. A review DOI Creative Commons

Åsa Lankinen,

Johanna Witzell, Kristin Aleklett

et al.

Agronomy for Sustainable Development, Journal Year: 2024, Volume and Issue: 44(2)

Published: April 1, 2024

Abstract Plant production systems worldwide are struggling to meet the diverse and increasing needs of humankind while also facing challenges such as climate change biodiversity loss. This, combined with desirable transition from use conventional pesticides more sustainable plant protection solutions, has led an urgent, increasing, need for low-risk products (PPPs) be developed, applied, integrated into management practices across all types systems. Despite a high demand end users consumers together joint political goals at EU level replace pesticides, number PPPs on European market remains low, in comparison synthetic agrochemicals. In this review, we summarize knowledge about policy, technical, administrative issues hampering process bringing new market. We present overview using that currently available within agricultural, horticultural, forestry sectors. describe variation modes action limitations associated different application techniques give concrete examples problems solutions Swedish sectors, contrast global perspectives demonstrated by African agriculture. Finally, conclude trans-sectoral, multi-actor approaches required provide suggestions how address remaining gaps related efficiency, application, economics PPP Integrated Pest Management (IPM) improve future food security Europe.

Language: Английский

Citations

10

A Responsible Framework for Applying Artificial Intelligence on Medical Images and Signals at the Point of Care: The PACS-AI Platform DOI Creative Commons
Pascal Thériault-Lauzier,

Denis Cobin,

Olivier Tastet

et al.

Canadian Journal of Cardiology, Journal Year: 2024, Volume and Issue: 40(10), P. 1828 - 1840

Published: June 15, 2024

The potential of artificial intelligence (AI) in medicine lies its ability to enhance clinicians' capacity analyse medical images, thereby improving diagnostic precision and accuracy thus enhancing current tests. However, the integration AI within health care is fraught with difficulties. Heterogeneity among system applications, reliance on proprietary closed-source software, rising cybersecurity threats pose significant challenges. Moreover, before their deployment clinical settings, models must demonstrate effectiveness across a wide range scenarios be validated by prospective studies, but doing so requires testing an environment mirroring workflow, which difficult achieve without dedicated software. Finally, use techniques raises legal ethical issues, such as protection patient privacy, prevention bias, monitoring device's safety for regulatory compliance. This review describes challenges provides guidelines how move forward. We describe open-source solution that we developed integrates into Picture Archives Communication System (PACS), called PACS-AI. approach aims increase evaluation facilitating validation existing imaging databases. PACS-AI may overcome many barriers offer pathway toward responsible, fair, effective care. In addition, propose list criteria researchers should adopt when publishing model standardisation reproducibility.

Language: Английский

Citations

10

Panel stacking is a threat to consensus statement validity DOI
Kasper P. Kepp,

Preben Aavitsland,

Marcel Ballin

et al.

Journal of Clinical Epidemiology, Journal Year: 2024, Volume and Issue: 173, P. 111428 - 111428

Published: June 17, 2024

Language: Английский

Citations

6

Impact assessment culture in the European Union. Time for something new? DOI Creative Commons
Andrea Saltelli, Marta Kuc‐Czarnecka, Samuele Lo Piano

et al.

Environmental Science & Policy, Journal Year: 2023, Volume and Issue: 142, P. 99 - 111

Published: Feb. 16, 2023

Current approaches and cultures for the economic evaluations of environmental health policies may suffer from excessive reliance on a standard neoclassic toolbox that neglects alternative perspectives. This prematurely limit spectrum available policy options. Here we show how inclusion neglected currents thought such as non-Ricardian economics, bioeconomics set qualitative-quantitative methods post-normal science leads to richer perspectives more inclusive uses quantitative evidence, opens analysis possible futures. We also present some case studies in energy, water, climate domains highlight point practical context policy-oriented audience. situate our recent calls EU social sciences humanities assessment works.

Language: Английский

Citations

12

Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19 DOI Open Access
David Scheim, Paola Vottero, Alessandro D. Santin

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(23), P. 17039 - 17039

Published: Dec. 1, 2023

Consistent with well-established biochemical properties of coronaviruses, sialylated glycan attachments between SARS-CoV-2 spike protein (SP) and host cells are key to the virus’s pathology. SP attaches aggregates red blood (RBCs), as shown in many pre-clinical clinical studies, causing pulmonary extrapulmonary microthrombi hypoxia severe COVID-19 patients. heavily surfaces platelets (which, like RBCs, have no ACE2) endothelial (having minimal compound this vascular damage. Notably, experimentally induced RBC aggregation vivo causes same morbidities for COVID-19, including microvascular occlusion, clots, myocarditis. Key risk factors morbidity, older age, diabetes obesity, all characterized by markedly increased propensity clumping. For mammalian species, degree susceptibility correlates aggregability p = 0.033. five human betacoronaviruses, two common cold strains express an enzyme that releases attachments, while deadly SARS, MERS do not, although viral loads infections similar. These insights also explain previously puzzling efficacy certain generics against may support development future therapeutic strategies long COVID

Language: Английский

Citations

12

Mastodon over Mammon: towards publicly owned scholarly knowledge DOI Creative Commons
Björn Brembs, A. Lenardic, Peter Murray‐Rust

et al.

Royal Society Open Science, Journal Year: 2023, Volume and Issue: 10(7)

Published: July 1, 2023

Twitter is in turmoil and the scholarly community on platform once again starting to migrate. As with early internet, organizations are at forefront of developing implementing a decentralized alternative Twitter, Mastodon. Both historically conceptually, this not new situation for community. Historically, scholars were forced leave social media FriendFeed after it was bought by Facebook 2006. Conceptually, problems associated public discourse subjected whims corporate owners unlike those journals owned monopolistic corporations: both cases perils good private hands palpable. For short form (Twitter/Mastodon) longer (journals) discourse, solutions exist, some which already enjoying institutional support. Here we argue that organizations, particular learned societies, now facing golden opportunity rethink their hesitations towards such alternatives support migration from Mastodon hosting instances. Demonstrating capable creating truly square impervious takeover, might renew confidence inspire focus analogous remaining record—encompassing text, data code—to safeguard all publicly knowledge.

Language: Английский

Citations

11

Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern its Morbidities and Inform Therapeutic Responses. ADDENDUM DOI Open Access
David Scheim, Peter Parry, David J. Rabbolini

et al.

Published: April 20, 2024

Consistent with the biochemistry of coronaviruses as well established over decades, SARS-CoV-2 makes its initial attachment to host cells through binding spike protein (SP) sialylated glycans (containing monosaccharide sialic acid) on cell surface. The virus can then slide and enter via ACE2. SP attaches particularly tightly trillions red blood (RBCs), platelets endothelial in human body, each very densely coated acid surface molecules but having no ACE2 or minimal These interlaced attachments trigger aggregation, microvascular occlusion vascular damage that underlie hypox-ia, clotting related morbidities severe COVID-19. Notably, two betacoro-naviruses express a acid-cleaving enzyme are benign, while other three—SARS, MERS—are virulent. RBC aggregation experimentally induced several animal species using an injected polysaccharide caused most same This glycan is key disentangling controversies have arisen efficacy certain generic COVID-19 treatment agents safety SP-based vaccines. More broadly, disregard for active physiological role RBCs yields unreliable erroneous report-ing pharmacokinetic parameters routinely obtained drugs bioactive detection plasma, whole-blood levels being up 30-fold higher. Appreciation elucidate underpinnings health conditions, in-cluding cardiovascular disease, therapeutic opportunities address them. [This preprint addendum published paper title abstract above, it covers issues science policy integrity not directly biochemical focus paper. formatting used this was applied be consistent paper.]

Language: Английский

Citations

4

Who is an AI Ethicist? An Empirical Study of Expertise, Skills, and Profiles to Build a Competency Framework DOI
Mariangela Zoe Cocchiaro, Jessica Morley, Claudio Novelli

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

4